MEDFRIEND LTD

What MEDFRIEND LTD does

MedFriend Ltd is a London-based, founder-led consultancy founded in 2025 that provides strategic advisory and operational support to biotech, pharmaceutical, clinical research, and digital health organisations. The company operates a portfolio of consulting service lines — MedFriend Growth, MedFriend Consulting, MedFriend Marketing, MedFriend Market Analysis, and MedFriend R&D Outsourcing — covering go-to-market strategy, regulatory and operational readiness, CRO selection support, and B2B marketing, delivered through embedded partnerships with clients across the UK, EU, and emerging European markets.

Its proprietary technology stack centres on two platforms. HESKM™ is a proprietary, auditable CRO procurement platform supporting transparent RFI/RFP management, vendor shortlisting, bid defence meetings, and operational oversight across clinical outsourcing engagements. MedFriend Health, scheduled to launch in Q2 2026, is a digital healthcare platform offering secure video consultations, patient record access, and patient–clinician interactions, positioned to support private clinics, insurers, and employers as a workplace benefit and to underpin decentralised clinical trials.

Commercially, MedFriend operates a sales-led, enterprise-focused GTM combining professional services (consulting engagements, advisory retainers, marketing services) with a future subscription/recurring revenue stream from the MedFriend Health platform once launched. Pricing is quote-based and tailored per engagement; no tiers or fee structures are publicly disclosed. The firm is privately held with no external funding rounds, no disclosed revenue, and a headcount of 1–10 employees. Distribution relies on direct outreach, content marketing via its blog and LinkedIn presence, and industry-event positioning (notably PCMG26 in Berlin).

Name

MEDFRIEND LTD

Legal name

MedFriend Ltd

Website

https://medfriend.health/

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

MedFriend Ltd is a London-based consultancy and digital health provider offering strategic advisory, CRO procurement (HESKM™), and a forthcoming digital healthcare platform (MedFriend Health) to biotech, pharma, clinics, insurers, and employers across the UK and EU.

Ownership category

akta.pro rank

Product category

Healthcare and Life Sciences Consulting

NAICS

Management Consulting Services (54161), Marketing Consulting Services (541613), Administrative Management and General Management Consulting Services (541611)

SIC

Services-Management Consulting Services (8742), Services-Health Services (8000)

akta.pro primary industry

Patient Relationship Management (PRM) & CRM for Provider Growth (Marketing/Outreach) (HLACAEAO)

akta.pro secondary industries

Healthcare & Life Sciences PR (BPAFADAJ), Healthcare & Life Sciences PR (MPAAADAD)

Keywords

• Clinical research consulting
• CRO procurement services
• Digital health platforms
• Life sciences advisory
• Biotech vendor selection

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Strategic Consulting Services: Advisory and consulting services including clinical research strategy, CRO selection, go-to-market planning, market analysis, operational readiness, and process optimisation for life sciences, biotech, medtech, and digital health companies.
2. Digital Health Platform Subscription: Digital healthcare platform offered to private clinics, insurers, and employers as workplace benefits or clinical trial support. Revenue generated through platform licensing and service delivery.
3. Marketing Services: B2B marketing strategy, social media management, content creation, thought leadership development, conference support and campaign planning for healthcare and life sciences organisations.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

MedFriend provides strategic consulting services and proprietary digital platforms to healthcare, life sciences, biotech, and clinical research organisations. Its consulting practice covers clinical research outsourcing, CRO selection, growth and marketing strategy, market analysis, and operational improvement, while its proprietary technology assets include HESKM™, a CRO procurement platform, and the MedFriend Health digital healthcare platform for clinics, insurers, employers, and decentralised clinical trials.

Product overview

MEDFRIEND LTD operates as a digital health and life sciences consultancy offering an integrated portfolio of proprietary platforms and consulting services. The core product portfolio comprises two main platforms: MedFriend Health, a B2B digital healthcare platform connecting patients, clinics, insurers, and employers with secure video consultations, patient record access, and decentralised clinical trial support (launching Q2 2026); and HESKM™, a proprietary CRO procurement platform supporting transparent, auditable vendor selection, RFI/RFP management, bid defence, and operational oversight. These platforms are complemented by consulting services including MedFriend Growth (strategic growth planning), MedFriend Marketing (B2B marketing and content), MedFriend Consulting (operational and regulatory advisory), MedFriend Market Analysis (market intelligence), and MedFriend R&D Outsourcing (CRO selection support). The combined offering enables the company to bridge patient needs with organisational goals across healthcare and life sciences.

Differentiator

Problem solved

Functional benefit

Brands

• HESKM™: Proprietary CRO procurement platform supporting transparent vendor selection, RFI/RFP management, bid defence, and operational oversight for clinical research and healthcare delivery.

Products and services

• MedFriend Health Digital healthcare platform connecting patients, clinics, insurers, and employers, offering secure video consultations, patient record access, and digital interaction between patients and healthcare professionals. Targets private clinics, insurers, and employers as a workplace benefit and supports decentralised clinical trials.
• HESKM™

Quantifiable outcome

• Reduces avoidable protocol amendments that typically cost USD 150,000 in Phase II and USD 535,000 in Phase III
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Medable: Decentralised clinical trial platform offering eCOA, eConsent, telehealth, and patient-engagement tools. Direct comparable because MedFriend Health's decentralised-trial and patient-engagement capability targets the same biotech and pharma buyers with overlapping functionality.
• Science 37: Decentralised and hybrid clinical trial operator with a patient-facing platform and telemedicine layer. Direct comparable to MedFriend Health's decentralised-trial support offering for biotech and pharma sponsors.

Broad incumbents

• IQVIA: Global CRO and life-sciences services giant spanning clinical operations, R&D outsourcing advisory, real-world evidence, and technology. Overlaps with MedFriend's CRO procurement advisory and clinical-development strategy services, but at vastly greater scale and as part of a broader portfolio.
• Veeva Systems: Life-sciences cloud platform providing CTMS, eTMF, vault-based clinical and commercial software. Comparable as an established software-enabled provider to the same biotech and pharma CRO-management workflows that HESKM™ addresses, though operating at enterprise scale across many adjacent use cases.
• ICON plc: Global CRO providing clinical development, laboratory, and commercialisation services. Comparable as a large incumbent MedFriend competes against in CRO-selection advisory discussions with biotech and pharma clients.
• Parexel: Major global CRO with deep biotech and pharma client base and full clinical-operations portfolio. Comparable as an incumbent MedFriend's clients weigh against when running CRO-selection engagements under HESKM™.
• Certara: Drug-development consultancy and software company specialising in model-informed drug development, regulatory science, and clinical pharmacology. Overlaps with MedFriend's life-sciences consulting and market-analysis offerings from a science-and-regulatory perspective.
• ZS Associates: Global consulting firm with a large healthcare and life-sciences practice covering strategy, commercialisation, and analytics for pharma and biotech. Comparable to MedFriend's market-entry, growth strategy, and operational advisory service lines, though serving a more enterprise client base.

Emerging players

• Definitive Healthcare: Healthcare commercial intelligence and market-analytics platform used by life-sciences companies for provider, market, and competitive insights. Comparable to MedFriend's MedFriend Market Analysis offering as a data-enabled complement to consulting engagements.
• CluePoints: Risk-based monitoring and central statistical monitoring software for clinical trials, used by sponsors and CROs to improve data quality and reduce amendments. Comparable as an emerging software vendor in the clinical-operations risk-and-quality space adjacent to HESKM™'s procurement focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/medfriendhealth
• Instagraminstagram.com/medfriend.ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MEDFRIEND LTD